Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival

Background Laparoscopic surgery for colon cancer has been demonstrated in clinical trials to have short-term benefits when compared to the open surgical approach. Guidelines of the National Comprehensive Cancer Network recommend that patients with stage III or high-risk stage II colon cancer undergo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Surgery 2017-06, Vol.161 (6), p.1633-1641
Hauptverfasser:	Kim, Roger H., MD, Kavanaugh, Mindie M., MD, Caldito, Gloria C., PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adenocarcinoma - pathology Adenocarcinoma - surgery Adult Aged Aged, 80 and over Chemotherapy, Adjuvant Colectomy - methods Colectomy - mortality Colonic Neoplasms - drug therapy Colonic Neoplasms - mortality Colonic Neoplasms - pathology Colonic Neoplasms - surgery Databases, Factual Disease-Free Survival Female Guideline Adherence - statistics & numerical data Humans Laparoscopy - methods Laparoscopy - mortality Laparotomy - methods Laparotomy - mortality Logistic Models Male Middle Aged Neoplasm Invasiveness - pathology Neoplasm Staging Practice Guidelines as Topic Prognosis Retrospective Studies Risk Assessment Surgery Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Laparoscopic surgery for colon cancer has been demonstrated in clinical trials to have short-term benefits when compared to the open surgical approach. Guidelines of the National Comprehensive Cancer Network recommend that patients with stage III or high-risk stage II colon cancer undergo adjuvant chemotherapy. We hypothesized that laparoscopic colectomy is associated with increased compliance to recommendations for chemotherapy, a lesser time to start of chemotherapy, and increased overall survival. Methods The National Cancer Data Base was queried to identify patients with stage III or high-risk stage II colon cancer (T4, positive margins,
ISSN:	0039-6060 1532-7361
DOI:	10.1016/j.surg.2016.11.024